A few weeks ago, the Taliban regime in Afghanistan announced that it had reached an agreement with a company to grow and manufacture cannabis products in the country. Through social media, the Ministry of Interior reported that a company called Cpharm would make an investment of more than $400 million to create a factory to produce marijuana. What Happened? A media scramble set the spotlight on a small consulting firm outside Sydney, Australia, called Cpharm. Quickly, through a statement, the company denied having any relationship with the regime. “We have no relationship with cannabis or the Taliban. We have no idea where the Taliban statement has come from in the media and we want to assure everyone that it must not be related to Cpharm Pty Ltd Australia,” they assured. After the media hype, Qari Saeed Khosty, the Taliban spokesman, tweeted to set the record straight: The deal had been finalized with a German company dedicated to the development of cannabinoid-based medicines called Cpharm.
El Planteo, The Fresh Toast, 12/22/2021 14:00:00